🔗 Share this article

The prestigious award in medical science was granted for transformative findings that illuminate how the body's defense network targets harmful pathogens while protecting the healthy tissues.

Three renowned researchers—Japan's Prof. Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—received this accolade.

Their work uncovered specialized "sentinels" within the defense system that remove malfunctioning defense cells capable of harming the organism.

The findings are now enabling innovative treatments for autoimmune diseases and malignancies.

The laureates will divide a monetary award worth 11 million Swedish kronor.

Crucial Findings

"The work has been essential for understanding how the body's defenses functions and the reason we do not all suffer from severe self-attack conditions," stated the chair of the Nobel Committee.

The team's research explain a fundamental question: In what way does the immune system protect us from countless invaders while keeping our own tissues unharmed?

The body's protection system employs white blood cells that scan for signs of infection, including viruses and bacteria it has never encountered.

Such defenders utilize detectors—known as receptors—that are produced by chance in a vast number of variations.

That gives the immune system the ability to combat a wide array of threats, but the unpredictability of the mechanism inevitably creates immune cells that may target the body.

Protectors of the Body

Scientists earlier understood that a portion of these harmful white blood cells were eliminated in the immune organ—where immune cells develop.

The latest award recognizes the identification of regulatory T-cells—described as the immune system's "security guards"—which travel through the body to neutralize other immune cells that assault the body's own tissues.

It is known that this mechanism fails in autoimmune diseases such as juvenile diabetes, MS, and RA.

A Nobel panel added, "The findings have established a new field of investigation and spurred the development of new therapies, for example for cancer and immune disorders."

Regarding cancer, regulatory T-cells block the body from fighting the growth, so research are focused on lowering their quantity.

In self-attack disorders, trials are exploring boosting regulatory T-cells so the body is no longer under attack. A similar method could also be useful in minimizing the risks of organ transplant failure.

Innovative Studies

Prof Sakaguchi, from a Japanese institution, conducted experiments on rodents that had their thymus removed, leading to autoimmune disease.

He showed that injecting defense cells from other animals could stop the disease—implying there was a system for preventing defenders from harming the body.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an inherited autoimmune disease in rodents and people that led to the discovery of a gene vital for how T-regs operate.

"Their pioneering work has revealed how the body's defenses is kept in check by regulatory T cells, preventing it from accidentally targeting the healthy cells," commented a prominent physiology specialist.

"This work is a remarkable illustration of how basic physiological research can have far-reaching implications for human health."